Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,662 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A unique view of SARS-CoV-2 through the lens of ORF8 protein.
Hassan SS, Aljabali AAA, Panda PK, Ghosh S, Attrish D, Choudhury PP, Seyran M, Pizzol D, Adadi P, Abd El-Aziz TM, Soares A, Kandimalla R, Lundstrom K, Lal A, Azad GK, Uversky VN, Sherchan SP, Baetas-da-Cruz W, Uhal BD, Rezaei N, Chauhan G, Barh D, Redwan EM, Dayhoff GW 2nd, Bazan NG, Serrano-Aroca Á, El-Demerdash A, Mishra YK, Palu G, Takayama K, Brufsky AM, Tambuwala MM. Hassan SS, et al. Among authors: rezaei n. Comput Biol Med. 2021 Jun;133:104380. doi: 10.1016/j.compbiomed.2021.104380. Epub 2021 Apr 15. Comput Biol Med. 2021. PMID: 33872970 Free PMC article.
Lymphopenia in COVID-19: Therapeutic opportunities.
Fathi N, Rezaei N. Fathi N, et al. Among authors: rezaei n. Cell Biol Int. 2020 Sep;44(9):1792-1797. doi: 10.1002/cbin.11403. Epub 2020 Jun 3. Cell Biol Int. 2020. PMID: 32458561 Free PMC article. Review.
SARS-CoV-2-A Tough Opponent for the Immune System.
Nasab MG, Saghazadeh A, Rezaei N. Nasab MG, et al. Among authors: rezaei n. Arch Med Res. 2020 Aug;51(6):589-592. doi: 10.1016/j.arcmed.2020.05.020. Epub 2020 May 30. Arch Med Res. 2020. PMID: 32532524 Free PMC article.
Monoclonal antibody as a potential anti-COVID-19.
Jahanshahlu L, Rezaei N. Jahanshahlu L, et al. Among authors: rezaei n. Biomed Pharmacother. 2020 Sep;129:110337. doi: 10.1016/j.biopha.2020.110337. Epub 2020 Jun 4. Biomed Pharmacother. 2020. PMID: 32534226 Free PMC article. Review.
Immunotherapy for SARS-CoV-2: potential opportunities.
Pashaei M, Rezaei N. Pashaei M, et al. Among authors: rezaei n. Expert Opin Biol Ther. 2020 Oct;20(10):1111-1116. doi: 10.1080/14712598.2020.1807933. Epub 2020 Aug 12. Expert Opin Biol Ther. 2020. PMID: 32762581 Free PMC article. No abstract available.
Cytokines and COVID-19: friends or foes?
Rokni M, Hamblin MR, Rezaei N. Rokni M, et al. Among authors: rezaei n. Hum Vaccin Immunother. 2020 Oct 2;16(10):2363-2365. doi: 10.1080/21645515.2020.1799669. Epub 2020 Aug 25. Hum Vaccin Immunother. 2020. PMID: 32841579 Free PMC article.
Questions concerning the proximal origin of SARS-CoV-2.
Seyran M, Pizzol D, Adadi P, El-Aziz TMA, Hassan SS, Soares A, Kandimalla R, Lundstrom K, Tambuwala M, Aljabali AAA, Lal A, Azad GK, Choudhury PP, Uversky VN, Sherchan SP, Uhal BD, Rezaei N, Brufsky AM. Seyran M, et al. Among authors: rezaei n. J Med Virol. 2021 Mar;93(3):1204-1206. doi: 10.1002/jmv.26478. Epub 2020 Dec 30. J Med Virol. 2021. PMID: 32880995 Free PMC article. No abstract available.
1,662 results